Pronutria co-founder Flagship Ventures backs again in $39m Series C

Pronutria Biosciences founding backer Flagship Ventures was among investors in a $39m Series C financing round for the company, which is developing amino acid treatments for muscle, metabolic, neurological and liver disorders.